| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |